摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-3-chloro-2-hydroxypropyl 4-methylbenzenesulfonate | 83398-53-2

中文名称
——
中文别名
——
英文名称
(R)-3-chloro-2-hydroxypropyl 4-methylbenzenesulfonate
英文别名
(R)-3-chloro-2-hydroxypropyl-1-(tolune-4-sulfonate);(R)-2-hydroxy-3-chloropropyl p-toluenesulfonate;3-chloro-2(R)-hydroxy-1-tosylpropane;(R)-1-chloro-3-tosyloxypropan-2-ol;(R)-3-chloro-2-hydroxy-1-o.tosyl-propanol;[(2R)-3-chloro-2-hydroxypropyl] 4-methylbenzenesulfonate
(R)-3-chloro-2-hydroxypropyl 4-methylbenzenesulfonate化学式
CAS
83398-53-2
化学式
C10H13ClO4S
mdl
——
分子量
264.73
InChiKey
YCZXDGPMENOKSA-VIFPVBQESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    72
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Preparation of Optically Active 1,2-Diol Monotosylates by Enzymatic Hydrolysis
    作者:Kazutsugu Matsumoto、Yasutaka Shimada、Hiroshi Sato、Shinji Minowa
    DOI:10.1055/s-2008-1032047
    日期:2008.2
    An easy preparation of optically active 1,2-diol monotosylate derivatives by enzymatic hydrolysis is disclosed. Lipase PS ( BURKHOLDERIA CEPACIA) catalyzes the hydrolysis of racemic 2-acetoxyhexyl tosylate with excellent enantioselectivity to afford the corresponding optically active compounds. In this reaction, a unique temperature effect is observed. After optimizing the reaction conditions, this
    公开了通过酶促解容易制备光学活性的1,2-二醇甲苯磺酸酯生物脂肪酶 PS (BURKHOLDERIA CEPACIA) 以优异的对映选择性催化外消旋甲苯磺酸 2-乙酰氧基己酯的解,以提供相应的旋光化合物。在该反应中,观察到独特的温度效应。优化反应条件后,该方法可广泛应用于各种高ee光学活性化合物的两种对映体的实际制备。
  • [EN] CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY<br/>[FR] COMPOSÉS CHIMIQUES COMME INHIBITEURS DE L'ACTIVITÉ INTERLEUKINE-1
    申请人:JECURE THERAPEUTICS INC
    公开号:WO2018136890A1
    公开(公告)日:2018-07-26
    The present disclosure relates to novel sulfonylurea and sulfonyl thiourea compounds and related compounds and their use in treating a disease or condition responsive to modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
    本公开涉及新型磺酰和磺酰硫脲化合物以及相关化合物,以及它们在治疗对细胞因子如IL-1β和IL-18的调节敏感的疾病或状况中的应用,调节NLRP3或抑制NLRP3或相关炎症过程组分的激活。
  • Method for preparing L-carnitine
    申请人:Anic S.p.A.
    公开号:US04413142A1
    公开(公告)日:1983-11-01
    L-carnitine is prepared by a synthesizing process starting from D-mannitol. The synthesis is started with the formation of a D-mannitol ketonide (more specifically D-mannitol acetonide from D-mannitol and acetone, whereafter the D-mannitol is split by oxidation to give glyceraldehyde acetonide, which is further reduced to glycerol acetonide. Then the free hydroxyl group is exchanged with a halogen atom (chlorine) with the formation of chlorodihydroxy propane, the primary alcoholic group of which is functionalized with the acid chloride of a sulfonic acid (tosylchloride). The reaction of the tosyl derivative with the salt of hydrogen cyanide leads to the formation of the corresponding nitrile which, when reacted with trimethylamine gives carnitinonitrile. The nitrile group is now hydrolyzed to give L-carnitine chloride. The formation of L-carnitine can then be obtained by exchanging the chloride ion with a hydroxyl ion.
    左旋肉碱是通过从D-甘露醇开始的合成过程制备的。合成过程始于形成D-甘露醇酮酸酯(更具体地说是D-甘露醇乙酸酯,由D-甘露醇丙酮反应而成),随后D-甘露醇被氧化分解为甘油乙酸酯,进一步还原为甘油醇乙酸酯。然后,游离的羟基团与卤素原子()交换,形成二羟基丙烷,其主要醇基与磺酸对甲苯磺酰氯)的酸基发生功能化。磺酸生物化氢盐反应形成相应的腈,当与三甲胺反应时生成肉腈。腈基现在被解成左旋肉碱盐酸盐。通过用氢氧根离子交换氯离子,可以得到左旋肉碱的形成。
  • Enzymatic method of making 1,2-diol derivatives and their esters with succine anhydride
    申请人:Hwang Ook Soon
    公开号:US20060234362A1
    公开(公告)日:2006-10-19
    The present invention relates to a new process for the preparation of optically active alcohols represented by the general formula 2 and their esters represented by the general formula 3 in scheme 1. In more detail, this invention relates to the process for the preparation of optically active alcohols and their esters which are used as pharmaceutical intermediates by reacting the hydroxyl group stereospecifically by lipase after adding racemic alcohols represented by the general formula 1 and succinic anhydride as an acylating agent to the organic solvent. According to this invention, the primary hydroxyl group of 1,2-diols is transformed by other functional group and the secondary hydroxyl group is esterified stereospecifically with succinic anhydride as an acylating agent. Optically active alcohols and their esters of high optical purity in high yield can be produced by using succinic anhydride as an acylating agent because alcohols can be separated from their esters more easily than those of other conventional methods.
    本发明涉及一种制备光学活性醇的新工艺,其通式为2,以及它们的酯,其通式为3,如图1所示。更详细地说,本发明涉及一种制备光学活性醇及其酯的工艺,通过在有机溶剂中加入通式1的混合醇和琥珀酸酐作为酰化试剂后,通过脂肪酶立体特异性地反应羟基基团。根据本发明,1,2-二醇的主要羟基基团被转化为其他官能团,次要羟基基团通过琥珀酸酐作为酰化试剂被立体特异性地酯化。由于醇可以比其他传统方法更容易地与它们的酯分离,因此可以使用琥珀酸酐作为酰化试剂生产高光学纯度和高收率的光学活性醇及其酯。
  • Process for the enzymatic separation of the optical isomers of tosyloxy-alkanols
    申请人:MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA
    公开号:EP0490407A2
    公开(公告)日:1992-06-17
    Described is a process for the biotechnological resolution, by means of stereoselective enzymatic esterification, of the racemic mixture of optical isomers of tosyloxy-alkanols of general formula (I): wherein R represents an alkyl, haloalkyl or C2-Cio alkenyl group, either linear or branched, and n is 1 or 2, by using aliphatic acid anhydrides in the presence of an enzyme which is capable of selectively catalyzing the esterification of the (R) isomer, leaving the (S) isomer basically unchanged.
    本发明描述了一种通过立体选择性酶法酯化,以生物技术解决通式(I)的对羟基烷 醇光学异构体外消旋混合物的工艺: 其中 R 代表直链或支链烷基、卤代烷基或 C2-Cio 烯基,n 为 1 或 2,使用脂肪族酸酐,在一种酶的存在下,该酶能选择性地催化(R)异构体的酯化反应,而(S)异构体基本不变。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫